However, his GP did not inform him about the drug's potential side effects, which include impulse control disorders such as ...

Everything we do changes our brain in some way. The very act of reading this sentence will (very) subtly alter your brain chemistry. However, drugs of abuse such as cocaine, cannabis and ecstasy set ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

An estimated one-quarter to one-third of people with schizophrenia have symptoms that don’t improve with traditional ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs' ...

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Tavapadon hit the primary endpoint in one phase 3 trial in April, before AbbVie closed the takeover, and racked up another victory in September. AbbVie completed the set Monday by reporting data from ...

According to GlobalData’s Drugs Database, the schizophrenia market remains dominated by dopamine-targeted mechanisms, such as ...

Outdoor Research has done its homework in designing a ridiculously comfortable pair of riding duds. Keeping in line with the ...

Electronic devices give us plenty of enjoyment nowadays, but Dr. Alok Kinojia says this has "raised the bar" for what it ...